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INTRODUCTION 
Validation is an integral part of quality assurance; it 
involves the systematic study of systems, facilities and 
processes aimed at determining whether they perform their 
intended functions adequately and consistently as 
specified. A validated process is one which has been 
demonstrated to provide a high degree of assurance that 
uniform batches will be produced that meet the required 
specifications and has therefore been formally approved. 
Validation in itself does not improve processes but 
confirms that the processes have been properly developed 
and are under control.3 
USFDA defines validation as: “Validation isestablishing 
documented evidence whichprovides a high degree of 
assurance that aspecific process will consistently produce 
aproductmeetingits pre-determinedspecifications and 
quality characteristics. According to European 
commission: Validation isdefined as “Action providing in 
accordance withthe principles of GMP, that any procedure, 
process, equipment, material, activity or systemactually 
lead to the expected results.10 
 Process validation establishes the flexibility 
andconstraints in the manufacturing process controls in the 
attainment of desirable attributes in the drug product while 
preventing undesirable properties. This is an important 
concept, since it serves to support the underlying definition 
of validation, which is a systematic approach to 
identifying, measuring, evaluating, documenting, and re-
evaluating a series of critical steps in the manufacturing 
process that require control to ensure a reproducible final 
product.9 
A successful validation program depends upon information 
and knowledge from product and process development. 
This knowledge and understanding is the basis for 
establishing an approach to control of the manufacturing 
process that results in products with the desired quality 
attributes. Manufacturers should: 
•Understand the sources of variation 
•Detect the presence and degree of variation 
•Understand the impact of variation on the process and 
ultimately on product attributes 
•Control the variation in a manner commensurate with the 
risk it represents to the process and product7 
TYPES OF VALIDATION 
Prospective validation 
The objective of the prospective validation is to prove or 
demonstrate that the process will work in accordance with 
validation protocol prepared for the pilot production trials. 
Prospective validation should normally be completed prior 
to the distribution and sale of the medicinal product. In 
Prospective Validation, the validation protocol is executed 
before the process is put into commercial use. During the 
product development phase the production process should 
be broken down into individual steps. Each step should be 
evaluated on the basis of experience or theoretical 
considerations to determine the critical parameters that 
may affect the quality of the finished product. A series 
ofexperiments should be designed to determine the 
criticality of these factors. Each experiment should be 
planned and documented fully in an authorized protocol.11 
Concurrent validation 
It is aprocess where current production batches are used to 
monitor processing parameters. It gives of the present 
batch being studied, and offers limited assurance regarding 
consistency of quality from batch to batch. Concurrent 
Validation means establishing documented evidence a 
process does what it is supposed to based on data 
generated during actual implementation of the process. 
Concurrent validation may be the practical approach under 
certain circumstances. It is important in these cases when 
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the systems and equipment to be used have been fully 
validated previously. 
Retrospective validation 
Conducted fir a product already being marked, and is 
based on extensive data accumulated over several lots and 
over time. Retrospective Validation may be usedfor older 
products which were not validated by the fabricator at the 
time that they were first marketed, and which is now to be 
validated to confirm to the requirements of division 2, Part 
C of the Regulation to be Food and Drugs Act. 
Retrospective Validation is only acceptable for well 
established detailed processes and will be Inappropriate 
where there have recent changes in the formulation of the 
products, operatingprocedures, equipment and facility. 
Revalidation 
Re-validation is usually performed to the confirmation of 
initial validation for a Periodic review. Re-validation 
provides the evidence that changes in a process and /or the 
process environment that are introduced do not adversely 
affect process characteristics and product quality. 
Documentation requirements will be the same as for the 
initial validation of the process. Re-validation becomes 
necessary in certain situations.11 
PROCESS VALIDATION 
Process Validation is “Establishing documented evidence 
which provides a high degree of assurance that a specific 
process will consistently produce a product meeting its 
pre-determined specifications and quality attributes. 
Process validation involves a series of activities taking 
place over the lifecycle of the product and process. 
Thisguidance describes process validation activities in 
three stages. 
Stage 1 – Process Design: The commercial manufacturing 
process is defined during this stage based on knowledge 
gained through development and scale-up activities.  
Stage 2 – Process Qualification: During this stage, the 
process design is evaluated to determine if the process is 
capable of reproducible commercial manufacturing.  
Stage 3 – Continued Process Verification: Ongoing 
assurance is gained during routine production that the 
process remains in a state of control.  
A successful validation program depends upon information 
and knowledge from product and process development. 
This knowledge and understanding is the basis for 
establishing an approach to control of the manufacturing 
process that results in products with the desired quality 
attributes. Manufacturers should. 
 Understand the sources of variation  
 Detect the presence and degree of variation  
 Understand the impact of variation on the process 
and ultimately on product attributes. 
 Control the variation in a manner commensurate 
with the risk it represents to the process and product. 
Each manufacturer should judge whether it has gained 
sufficient understanding to provide a high degree of 
assurance in its manufacturing process to justify 
commercial distribution of theproduct. Focusing 
exclusively on qualification efforts without also 
understanding the manufacturing process and associated 
variations may not lead to adequate assurance of quality. 
After establishing and confirming the process, 
manufacturers must maintain the process in a state of 
control over the life of the process, even as materials, 
equipment, production environment, personnel, and 
manufacturing procedures change.6 
GENERAL CONSIDERATIONS FOR PROCESS 
VALIDATION 
In all stages of the product lifecycle, good project 
management and good archiving that capture scientific 
knowledge will make the process validation program more 
effective and efficient. The following practices should 
ensure uniform collection and assessment of information 
about the process and enhance the accessibility of such 
information later in the product lifecycle. 
 An integrated team approach to process validation that 
includes expertise from a variety of disciplines (e.g., 
process engineering, industrial pharmacy, analytical 
chemistry, manufacturing, and quality assurance). 
Project plans, along with the full support of senior 
management, are essential elements for success.  
 Throughout the product lifecycle, various studies can 
be initiated to discover, observe, correlate, or confirm 
information about the product and process 
 All studies should be planned and conducted 
according to sound scientific principles, appropriately 
documented, and approved in accordance with the 
established procedure appropriate for the stage of the 
lifecycle.  
 Many products are single-source or involve 
complicated manufacturing processes. Homogeneity 
within a batch and consistency between batches are 
goals of process validation activities. Validation offers 
assurance that a process is reasonably protected 
against sources of variability that could affect 
production output, cause supply problems, and 
negatively affect public health.  
 The terms attribute(s) (e.g., quality, product, 
component) and parameter(s) (e.g., process, operating, 
and equipment) are not categorized with respect to 
criticalityin this guidance.19 
TYPES OF PROCESS VALIDATION 
Prospective ProcessValidation 
In prospective process validation, an experimental plan 
called the validation protocolis executed (following 
completion of the qualification trials) before theprocess is 
put into commercial use. Most validation efforts require 
some degreeof prospective experimentation to generate 
validation support data. This particulartype of process 
validation is normally carried out in connection with 
theintroduction of new drug products and their 
manufacturing processes. 
Concurrent Process Validation 
In-process monitoring of critical processing steps and end-
product testing of current production can provide 
documented evidence to show that the manufacturing 
process is in a state of control. Such validation 
documentation can be provided from the test parameter 
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and data sources disclosed in the section on retrospective 
validation. 
Retrospective Process Validation 
The retrospective validation option is chosen for 
established products whose manufacturing processes are 
considered stable and when on the basis of economic 
considerations alone and resource limitations, prospective 
validation programs cannot be justified. Prior to 
undertaking retrospective validation, wherein the 
numerical in-process and/or end-product test data of 
historic production batches are subjected to statistical 
analysis, the equipment, facilities and subsystemsused in 
connection with the manufacturing process must be 
qualified in conformance with CGMP requirements. 
Process Re-Validation: 
Required when there is a change in any of the critical 
process parameters, formulation, primary packaging 
components, raw material fabricator, major equipment or 
premises. Failure to meet product and process 
specifications in batches would also require process re-
validation.12 
BASIC PRNCIPLE FOR PROCESS VALIDATION 
The basic principle for validation may be stated as follows: 
Installation Qualification (IQ): establishing byobjective 
evidence that all key aspects of the process equipment and 
ancillary system installation adhere to the manufacturer’s 
approved specification and that the recommendation of the 
supplier of the equipment are suitably considered. 
IQ considerations are: 
• Equipment design features (i.e. material ofconstruction 
cleanability, etc.) 
• Installation conditions (wiring, utility,functionality, etc.) 
• Calibration, preventative maintenance,cleaning 
schedules. 
• Safety features. 
• Supplier documentation, prints, drawingsand manuals. 
• Software documented. 
• Spare parts list. 
• Environmental conditions (such as cleanroom 
requirements, temperature, andhumidity). 
Operational Qualification (OQ): Establishing 
byobjective evidence process control limits andaction 
levels which result in product those allpredetermined 
requirements. 
OQ considerations include: 
• Process control limits (time, temperature, pressure, line 
speed, setup conditions, etc.) 
• Software parameters. 
• Raw material specifications 
• Process operating procedures. 
• Material handling requirements. 
• Process change control. 
• Training. 
• Short term stability and capability of theprocess, (latitude 
studies or control charts). 
• Potential failure modes, action levels andworst-case 
conditions. 
• The use of statistically valid techniques suchas screening 
experiments to optimize theprocess can be used during this 
phase. 
Performance Qualification (PQ): establishingby 
objective evidence that the process, underanticipated 
conditions, consistently produces aproduct which meets all 
predetermined requirements. 
PQ considerations include: 
• Actual product and process parameters andprocedures 
established in OQ. 
• Acceptability of the product. 
• Assurance of process capability asestablished in OQ. 
• Process repeatability, long term processstability. 
Re -Qualification: Modification to, or relocationof 
equipment should follow satisfactory reviewand 
authorization of the documented changeproposal through 
the change control procedure.This formal review should 
include considerationof re-qualification of the equipment. 
Minorchanges or changes having no direct impact onfinal 
or in-process product quality should behandled through the 
documentation system ofthe preventive maintenance 
program.16,17 
VALIDATION TEAM 
A multidisciplinary team is primarily responsible for 
conducting and supervising validation studies. Personnel 
qualified by training and experience in a relevant 
discipline may conduct such studies. The working party 
would usually include the following staff members such 
as; 
 Head of quality assurance. 
 Head of engineering. 
 Validation manager. 
 Production manager. 
 Specialist validation discipline: all areas. 
The validation team must be 
Prepare the site validation master plan with the specific 
requirements as per the company policy.  
 Meet regularly, In accordance with a defined 
schedule, to discuss the progress and compliance with 
the validation plan and schedule. 
 Determine the systems / equipment to be qualified / 
validated and the extent of validation to be carried 
out.  
 Determine the frequency of validation.  
 Prepare and evaluate the suitability of the protocols.  
 Verify the adequacy of the tests used for proving that 
the objectives are achieved.  
 Complied reports should be checked and approved by   
validation team members.Maintain records of 
validation studies and inform to the Corporate Quality 
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Assurance of progress in terms of validation plan and 
schedule 13.  
DOCUMENTATION  
Documentation at each stage of the process validation 
lifecycle is essential for effective communication in 
complex, lengthy, and multidisciplinary projects. 
Documentation is important so that knowledge gained 
about a product and process is accessible and 
comprehensible to others involved in each stage of the 
lifecycle. Information transparency and accessibility are 
fundamental tenets of the scientific method. They are also 
essential to enabling organizational units responsible and 
accountable for the process to make informed, science-
based decisions that ultimately support the release of a 
product to commerce8. 
VALIDATION LIFE CYCLE 
Validation is a continuing and evolving process. The 
validation process whichextends from the very basic to a 
very broadtheological and methodical investigation if how 
the system and processes perform. Its scope encompasses 
documentation revision control, training and maintenance 
of the system and process. Evidence of validation should 
be seen at the corporate level, and be reflected in the 
management structure. Validation is a method for building 
and maintaining quality14. 
 
 
Figure 1: Validation Life Cycle 
VALIDATION PROTOCOL 
A written plan of actions stating how process validation 
will be conducted, it will specify who will conduct the 
various tasks and define testing parameters, sampling 
plans, testing methods and specifications, will specify 
product characteristics, and equipment to be used. It must 
be specify the minimum number of batches to be used for 
validation studies, it must specify the acceptance criteria 
and who will sign \ approve \ disapprove the conclusions 
derived from such a scientific study. The validation 
protocol should contain the following elements, 
 Short description of the process.  
 Summary of critical processing steps to be investigated.  
 In process, finished product specification for release.  
 Sampling plans.  
 Departmental responsibility.  
 Proposed timetable.  
 Approval of protocol15.  
VALIDATION MASTER PLAN 
The validation master plan should provide an overview of 
the entire validation operation, itsorganizational structure, 
its content and planning.The main elements of it being the 
list/inventory of the items to be validated and the planning 
schedule. All validation activitiesrelating to critical 
technical operations, relevant to product and process 
controls within a firmshould be included in the validation 
master plan. It should comprise all prospective, concurrent 
and retrospective validations as well as revalidation. 
The Validation Master Plan should be a summary 
document and should therefore be brief, concise and clear. 
It should not repeat information documented elsewhere but 
should refer toexisting documents such as policy 
documents, SOP’s and validation protocols and reports. 
• The format and content should include: 
• Introduction: validation policy, scope, location and 
schedule. 
• Organizational structure: personnel responsibilities. 
• Plant/process/product description: rational for inclusions 
or exclusions and extent of validation. 
• Specific process considerations that are critical and those 
requiring extra attention. 
• Key acceptance criteria. 
• Documentation format. 
• Reference to the required SOPs. 
• Time plans of each validation project andsub-project. 
• List of products/ processes/ systems to bevalidated, 
summarized in a matrix format, validation approach. 
• Re-validation activities, actual status and future 
planning15. 
THE VALIDATION REPORT 
A written report should be available after completion of 
the validation, if found acceptable it should be approved 
and authorized. The report should include at least the 
following 
 Title and objective of study. 
 Reference to protocol. 
 Details of material. 
 Equipment. 
 Programes and cycles used. 
 Details of procedures and test methods. 
 Result. 
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 Recommendations on the limit and criteria to be 
applied on future basis.18 
IMPORTANCE OF PROCESS VALIDATION 
Assurance of Quality 
Validation is an extension of the concepts of quality 
assurance since close control of theprocess is necessary to 
assure product quality and it is not possible to control a 
processproperly without thorough knowledge of the 
capabilities of that process without validatedand controlled 
processes, it is impossible to produce quality products 
consistently. Endproduct testing, in the absence of 
validation, gives little assurance of quality for 
varietyreasons, among which are. 
1. Very limited sample size. 
2. The limited number of tests performed on a sample. For 
example, it is impractical to test for all potential impurities 
or contaminants. 
3. The limited sensitivity of the test. 
Process Optimization 
The optimization of a process for maximum efficiency, 
while maintaining quality standards, is a consequence of 
validation. Literal meaning of word to optimize is “To 
make as effective, perfect or useful as possible”. The 
optimization of the facility, equipment, systems, and 
processes results in a product that meets quality 
requirements at the lowest cost. 
Reduction of quality costs 
Quality costs are divided in to four categories. They are: 
a) Preventive costs. 
b) Appraisal costs. 
c) Internal failure costs. 
d) External failure costs. 
e.g. of internal failure costs: Any validated and controlled 
process will result in fewerinternal failures like; 
 Fewer rejects 
 Reworks 
 Re-tests 
 Re-inspection4 
CONCLUSION 
Validation has been proven assurance for the process 
efficiency and sturdiness and it is the full-fledged quality 
attributing tool for the pharmaceutical industries. 
Validation is the commonest word in the areas of drug 
development, manufacturing and specification of finished 
products. It also renders reduction in the cost linked with 
process monitoring, sampling and testing. Apart from all 
the consistency and reliability of a validated process to 
produce a quality product is the very important for an 
industry. Finally it can be concluded that process 
validation is a key element in the quality assurance of 
pharmaceutical product as the end product testing is not 
sufficient to assure the quality of finished product. 
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